Attending Physician
Associate Professor of Clinical Pediatrics, Keck School of Medicine of USC
  • Summary
  • Publications
  • Locations

Lynda K. Fisher, MD, is on the medical staff of Children’s Hospital Los Angeles in the Division of Endocrinology and Metabolism.  She is an associate professor of clinical pediatrics at the Keck School of Medicine of the University of Southern California.

Education

Medical School: 

State University of New York/Downstate College of Medicine/Brooklyn

Internship: 

Children's Hospital Los Angeles: Pediatrics Internship

Residency: 

Children's Hospital Los Angeles: Pediatric Residency

Fellowship: 

Children's Hospital Los Angeles: Growth/Development Disord; Children's Hospital Los Angeles: Pediatric Endocrinology

Accomplishments

Certification: 

Pediatrics: American Board of Pediatrics
Pediatric Endocrinology: American Board of Pediatrics

Awards: 

Best Doctor in America, 2006, 2007, 2008, 2009, 2010, 2011-16
Top Doctors in Pasadena 2009-2016
Lestradet Prize for Outstanding  Contributions to Education and Advocacy in Diabetes, International Society for Pediatric and Adolescent Diabetes, 28 October 2016
Physician of the Year, American Diabetes Association Los Angeles Region. 1 December 2016

 

Publications: 

Gitelman SE, Gottlieb PA, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Harris KM, Kanaparthi S, Phippard D, Ding L, Bluestone JA, Ehlers MR; ITN START Study Team. Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.  Diabetologia. 2016 Jun;59(6):1153-61. doi: 10.1007/s00125-016-3917-4. Epub 2016 Apr 6.

Gitelman SE, Gottlieb PA, Rigby MR, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, Ding L, Bluestone JA, Ehlers MR; START Study Team. Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinology. 2013 Dec;1(4):306-16. doi: 10.1016/S2213-8587(13)70065-2. Epub 2013 Aug 28.

de Beaufort CE, Lange K, Swift PG, Aman J, Cameron F, Castano L, Dorchy H, Fisher LK, Hoey H, Kaprio E, Kocova M, Neu A, Njolstad PR, Phillip M, Schoenle E, Robert JJ, Urukami T, Vanelli M, Danne T, Barrett T, Chiarelli F, Aanstoot HJ, Mortensen HB; Hvidoere Study Group. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009. Pediatric Diabetes. 2013 Sep;14(6):422-8. doi: 10.1111/j.1399-5448.2012.00922.x. Epub 2012 Sep 10. Erratum in: Pediatric Diabetes. 2014 May;15(3):260.

Fisher LK, Halvorson M. Future developments in insulin pump therapy: progression from continuous subcutaneous insulin infusion to a sensor-pump system.  Diabetes Educator. 2006 Jan-Feb;32(1 Suppl):47S-52S. Review. No abstract available.

American Diabetes Association., Lorber DL, Chavez RS, Dorman J, Fisher LK, Guerken S, Haas LB, Hill JV, Kendall D, Puisis M, Salomone K, Shansky RM, Wakeen B. Diabetes management in correctional institutions.  Diabetes Care. 2013 Jan;36 Suppl 1:S86-92. doi: 10.2337/dc13-S086. No abstract available.

4650 Sunset Blvd.
MS 61
Los Angeles, CA 90027
Phone: 323-361-4606Office

468 E. Santa Clara St.
Arcadia, CA 91006
Phone: 626-795-7177Office
Fax: 626-357-4052Fax